Skip to main content
Premium Trial:

Request an Annual Quote

Shame, Shame, Shame

Howard Richman, the former vice president of Biopure, is heading to jail, reports the Associated Press. During a complaint by Securities and Exchange Commission that accused Biopure executives of misleading their investors about their synthetic blood product's chances of being approved, Richman instructed his lawyer to say that he had terminal colon cancer — which he does not have. Richman pled guilty to obstruction of justice and was sentenced to three years in prison.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.